2.10. Statistical Analysis
Statistical analyses were performed using Graphpad Prism, Version 9.3.1 (GraphPad Software, La Jolla, CA, USA). Data are presented as mean with 95% confidence interval (CI), unless otherwise indicated. Normality tests were performed before all analyses. Data not conforming to normal distribution based on the Shapiro–Wilk test were log-transformed and indicated accordingly. The use of medication was considered in data analysis as covariate and deemed not significant for outcomes. Differences in D1 values between cherry and placebo groups were evaluated using parametric or non-parametric unpaired t-tests. Age, gender, BMI, and HEI scores were evaluated as covariates, but their effect on the dependent variables were deemed not significant (The effect of treatment, study day, and their interaction were evaluated using a mixed effect analysis or 2-way ANOVA followed by Šidák multiple comparison tests. When differences between cherry and placebo were significant at D1, the difference between D30 and D1 (Δ) was computed, and marginal means were determined considering D1 values as a covariate. Statistical differences between marginal means were determined by unpaired t-test (parametric or non-parametric). Data statistically significant (Spearman correlations analyses were performed in GraphPad Prism to determine r and 